Endometrial Carcinoma
The new human cell line EN has a TP53 mutation and a 1-day doubling time
Published in Women's Health Weekly, April 10th, 2003
According to a study from Japan, they created "a new cell line, EN, established from an invasive endometrioid adenocarcinoma of the uterine corpus in a 50 yr old patient. The cells show rapid growth in culture with a doubling time of 24.4 hrs and high migration activity."
"Monolayer cultured cells were polygonal in shape and showed a tendency to pile up without contact inhibition. Subcutaneous transplantation of the EN cells into nude mice formed solid tumors that were histologically diagnosed as adenocarcinoma, whereas no metastasis was observed. Cultured EN cells produced...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Epithelial Ovarian Cancer
Researchers develop first mouse model - Menopause
Estrogen plus progestin not helpful to quality of life, new national study shows - Cancer Biomarkers
Angiogenesis relates to recurrence in women with breast cancer - Exercise
Postmenopausal women with heart disease benefit from exercise regardless of HRT status - Gynecology
Exaggerated regulatory factors boost vascularization in women with adenomyosis - HIV/AIDS Pathogenesis
CCR5 genotype affects women's susceptibility to infection - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
